Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Kr@t0m closed/locked thread
#1
Hi Charon, I'm sorry regarding the Kr@t0m post. I read your post where you said soon it was going to become a sch. 1 product & when it happens you was shutting the thread down. I just didn't know it was going to be today. Had I'd known that, I would've never posted something on that thread. I would've also pm'd you with my apology but I'm not quite there yet. I'm sorry again.
Reply
#2
I am glad u posted this here.

I am absolutely shocked that kratom is a sch 1 effective sept 30.

What is our gvt doing to us?

I understand, mosca. My post in that thread was not clear. Don't even worry about it.

BUT, ATTENTION, PLEASE, GUYS, KRATOM IS BEING RESCHEDULED TO A SCH 1 EFFECTIVE SEPT 30.

We can no longer allow talk of it.

Further, Holy toledo.
Angel  It is Well with My Soul  Angel


Reply
#3
I heard it was state by state, thats crazy, glad its not national
your only as old as the last time you changed your mind !
Reply
#4
It is national. Only north carolina is refusing to go along with this.

And, just as with MMJ, we all know that regardless of what the states say, the feds rule on this.

Hope there is so much uproar, that this temp rescheduling will be reversed.
Angel  It is Well with My Soul  Angel


Reply
#5
Kratom is deemed a sch 1 drug effective 30 september. We can no longer discuss it here without arousing suspicion.

In the link above, I included the article explaining D E A decision.

David Kroll , CONTRIBUTOR


The kratom plant, Mitragyna speciosa, produces medicinally important alkaloids that are increasingly known to be of potential medical benefit, but with questionable abuse potential. Photo credit: Shutterstock

The U.S. Drug Enforcement Agency has filed a notice of intent (PDF) to place the southeast Asian plant called kratom to the most restrictive classification of the Controlled Substances Act. The plant, Mitragyna speciosa, and its two primary constituents, mitragynine and 7-hydroxymitragynine, will be temporarily placed onto Schedule I on September 30, according to a filing by the DEA at 8:45 am Eastern time today. The full announcement is scheduled to be published in the Federal Register tomorrow, August 31.

Various forms of kratom and teas made from the plant’s leaves are sold in cafes and on the internet. Their primary effect is to provide a short-lived peaceful and calm feeling that is described as pleasant. Consistent with this effect being opioid-like, anecdotal reports indicate that some users have used kratom to successfully recover from physical and psychological dependence on prescription opioids and heroin. Comments on my last report on kratom have also indicated the successful use of teas made from the plant in managing chronic pain without the side effects and addictive potential of prescription opioids like oxycodone, hydrocodone and morphine.


In the last two months, published research has pointed to why kratom might be a useful and safer alternative to prescription opioids. The main component of the herb, the alkaloid mitragynine, and its metabolite and oxidation product, 7-hydroxymitragynine, produce an effect on the mu subtype of opioid receptors away from many of the mechanisms that cause many opioid side effects. These alkaloids are now shown to be so-called G-protein biased ligands at the mu opioid receptor. This effect minimizes the engagement of an intracellular protein called beta-arrestin that among other effects, causes a reduction in opioid receptors on the surface of cells, leading to the tolerance and dose escalation commonly seen with prescription opioids.

The CDC has reported in July that kratom can be abused and that poison control centers have received over 660 calls between 2010 and 2015 regarding kratom intoxication. This report has been criticized as being relatively inconsequential given the small number of cases when compared with other legal and illegal intoxicants. In some cases listed as kratom intoxication, other illicit drugs were taken by the individuals.


The North Carolina state legislature recently decided not to restrict and criminalize use and sale of kratom–limiting it only to buyers over age 18–because of personal testimonials to the benefits of kratom teas. With the federal intent to place the herb and its bioactive constituents on Schedule I, the DEA is ignoring the increasing scientific literature on a potential beneficial medical use of the plant. Schedule I classification, used for drugs with no known medical use and high abuse potential, will certainly make subsequent research on the plant more difficult.


http://www.forbes.com/sites/davidkroll/2...b8a69c7924
Angel  It is Well with My Soul  Angel


Reply
#6
(08-30-2016, 08:11 PM)Charon Wrote: It is national.  Only north carolina is refusing to go along with this.

And, just as with MMJ, we all know that regardless of what the states say, the feds rule on this.

Hope there is so much uproar, that this temp rescheduling will be reversed.

The North Carolina legislature recently decided to restrict buying & selling to those over 18. The same decision was made in Illinois and a number of other states last year. However, as a Schedule I substance, it will be illegal to sell and/or possess in any state in the US. That's my understanding thus far.
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)